Advertisement
Advertisement

Hong Kong is having its worst year for listings in a decade

Hong Kong is having its worst year for IPOs since the outbreak of Sars

Around this time last year I wrote a preview of the IPOs expected to arrive on the Hong Kong market. It's telling that most of those same deals are still in the pipeline, twisting in some interminable pre-launch marketing limbo.

Take, for example, the permanent saga of China Everbright Bank. It eyed the launch of IPO marketing in July 2011, hiring no fewer than nine banks to sell its US$6 billion deal. But conditions were choppy, so it pulled back. The bank returned in August 2011, but again pulled back. It sounded investors again this summer but last week it formally axed its much reduced (up to US$2 billion) offer, citing a poor market.

China Everbright joins Sany Heavy Industry and Graff Diamonds, among other major issuers, pulling big IPOs from the Hong Kong market this year.

True, Hong Kong's new listing market is in a dreadful state. The few deals that have arrived have largely traded down, and the city is on track to have its worst year for IPOs since Sars in 2003. (See chart.)

Hongkongers have long looked to IPOs as a staple investment. New listings have normally given investors outsized returns to provide lift to their portfolios. Sometimes, a hot deal or a hot market works the whole city into a kind of mania. But not these days. The IPO market is on ice, and its absence is missed.

Hong Kong's largest IPO this year remains that of Inner Mongolia Yitai Coal for US$903 million equivalent. At the time of writing, its stock was trading some 2.8 per cent below its already cheap IPO offer price.

"The IPO market in Hong Kong remains challenging," says James Fleming, co-head of global capital markets, Asia-Pacific, at Bank of America Merrill Lynch.

Disappointing outcomes for overhyped listings in the United States, such as those by Facebook or Manchester United, put a damper on the market's appetite for IPOs - even beyond America's shores.

The euro-zone crisis has also hurt Hong Kong's IPO market, as has slowing growth in the mainland.

But there are local factors at play, too. Most critically, investors lost money on a string of Hong Kong listings brought in late 2011, and they have not forgotten. What's more, the institutional cornerstone investors who brought crucial backing to deals last year seem to have dropped out of the market.

The nature of issuers coming to Hong Kong has also changed in recent years, and arguably not for the better. Gone are the large, liquid Chinese state privatisations of the mid-2000s that gave investors instant trading gains. Hong Kong IPO issuance from the state sector in the year to date was less than 30 per cent of the total and is unlikely to rise significantly.

In its place are smaller and more international, private-sector issuers who come to Hong Kong because they think they can get a higher price in this market.

Investors also see meanly priced deals arriving amid a backdrop of global economic news that veers between gloomy and alarming. It's a lot of risk with little upside.

Hong Kong Exchanges and Clearing now admits issuers from 20 overseas jurisdictions (other than the mainland, Bermuda and the Cayman Islands). But, among international issuers, only L'Occitane and Prada trade above their offer prices.

Most of the others are also posting rather thin trading volumes in relation to their free floats. Rusal manages a meagre US$1 million in terms of its daily trading. The likes of SBI Holdings or Sunshine Oilsands trade on volumes of up to US$200,000 and, on some days, not at all. The fact no doubt fed into Sunshine Oilsands' recent decision to seek another listing, in Toronto.

It's hard to see many more of these international candidates tapping the market in Hong Kong with large flotations - at least in the short term. IPOs for Russian corporates En+ Group (Rusal's parent), EuroSibEnergo or Centrobuv have been on the cards for a while, but the recent closing by Russian broker Renaissance Capital of its offices in Hong Kong and on the mainland hardly constitutes a vote of confidence for these transactions.

Indeed, a number of mid-sized brokers - some of which were arguably attempting to capitalise on what was expected to be a cross-border listing bonanza - have called it quits in recent months.

Piper Jaffray of the US is pulling out of Hong Kong, while Samsung Securities, Daiwa Capital Markets and Mizuho Securities are cutting their equity and capital markets operations in the city.

And yet institutional investors cannot afford to remain out of the market for too long. They need to invest. Eventually, they may help create momentum for IPOs that could lure back Hong Kong retail investors.

Indeed, the Hong Kong IPO market has always been intensely momentum driven, flickering from on to off on the smallest turns of economic news or trading data - and that volatility has also helped fuel one of the world's largest markets for warrants. Certainly, the money is there and a long issuer queue is standing by. Eventually, both will align.

Asian fundamentals, overall, remain attractive, certainly when compared to Europe, and some attractive opportunities may be too hard to resist. A year-end IPO rush, as was seen last year and in many other years, is always possible.

"Issuers and investors need to be prepared for unexpected window openings. With stimulus plans potentially from China, Europe and the US, along with low current valuations … the potential for equity issuance will be very strong," says Marshall Nicholson, managing director, investment banking at China International Capital Corporation.

Seeking a listing first, with shareholders selling down (or issuers raising capital) later - as Swire Properties did recently - could therefore be a prudent strategy for some corporates.

Typically, the financial sector dominates the list of IPO hopefuls. This includes potential multibillion-dollar deals for China Guangfa Bank (previously known as Guangdong Development Bank), People's Insurance Company of China Group (PICC), Taikang Life Insurance, Bank of Shanghai and Harbin Bank.

In other industry sectors, a number of prospective issuers made attempts to tap investors in Hong Kong in past months, and could feasibly return if sentiment perks up.

These include XCMG Construction Machinery, Shanghai Fosun Pharmaceutical, China Railway Materials and Mongolian coal miner Erdenes Tavan Tolgoi.

Ultimately, what's most needed is for one (or perhaps more realistically, several) high-profile offerings to capture the imagination of institutional and retail investors - and to post attractive after-market gains, after significant oversubscription through high-quality books of demand.

That is more easily said that done, but Peter Burnett, chairman, global capital markets, Asia, at UBS, sums it up pretty well: "There is plenty of cash, there is a history of great deals, but investor confidence is thin on the ground at the moment. Once that is restored there will be no shortage of attractive IPOs".

Philippe Espinasse, a former investment banker, is the author of (HKU Press)

Post